ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
6,010.61
0.50%
US Tech 100
21,272.00
0.53%
Dow Jones
42,319.37
0.35%
Brent Oil
75.045
-3.21%
Bitcoin
105,787.59
1.04%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Prime Medicine Inc (PRME) Quote

Prime Medicine Inc

Prime Medicine Inc (PRME)

Prim SA
Prim SA
Prim SA
Prim SA
Prime Drink Group Corp
1.80
0.19
(11.46%)
Closed June 18 4:00PM
15 min delayed - Upgrade to Realtime
1.88
0.08
( 4.44% )
Pre Market: 9:21AM
15 min delayed - Upgrade to Realtime

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
1.88
Bid
1.85
Ask
1.88
Volume
29,623
0.00 Day's Range 0.00
1.11 52 Week Range 6.75
Market Cap
246.834M
Previous Close
1.80
Open
-
Last Trade
744
@
1.88
(formt)
Last Trade Time
09:21:37
Financial Volume
-
VWAP
-
Average Volume (3m)
2,107,822
Shares Outstanding
131,294,454
Dividend Yield
-
PE Ratio
-1.21
Earnings Per Share (EPS)
-1.49
Revenue
2.98M
Net Profit
-195.88M

About Prime Medicine Inc

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome a... Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.primemedicine.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Prime Medicine Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PRME. The last closing price for Prime Medicine was $1.80. Over the last year, Prime Medicine shares have traded in a share price range of $ 1.11 to $ 6.75.

Prime Medicine currently has 131,294,454 shares outstanding. The market capitalization of Prime Medicine is $236.33 million. Prime Medicine has a price to earnings ratio (PE ratio) of -1.21.

Ask ADVFN Intelligence (AI)

PRME Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 05 2025
PRME (11.46%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 05 2025
PRME (11.46%)

Form 8-K - Current report
Edgar (US Regulatory)
June 05 2025
PRME (11.46%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 08 2025
PRME (11.46%)

Form 8-K - Current report
Edgar (US Regulatory)
May 08 2025
PRME (11.46%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.4329.65517241381.451.971.432639101.65890787CS
40.6148.0314960631.271.971.1821703231.51233162CS
12-0.08-4.081632653061.962.111.1121078221.45076143CS
26-0.88-31.8840579712.763.591.1115901141.85160028CS
52-4.42-70.15873015876.36.751.1113892992.83007621CS
156-17.09-90.089615181918.9721.73011.118134405.41180725CS
260-17.09-90.089615181918.9721.73011.118134405.41180725CS

PRME - Frequently Asked Questions (FAQ)

What is the current Prime Medicine share price?
The current share price of Prime Medicine is $ 1.88
How many Prime Medicine shares are in issue?
Prime Medicine has 131,294,454 shares in issue
What is the market cap of Prime Medicine?
The market capitalisation of Prime Medicine is USD 236.33M
What is the 1 year trading range for Prime Medicine share price?
Prime Medicine has traded in the range of $ 1.11 to $ 6.75 during the past year
What is the PE ratio of Prime Medicine?
The price to earnings ratio of Prime Medicine is -1.21
What is the cash to sales ratio of Prime Medicine?
The cash to sales ratio of Prime Medicine is 79.3
What is the reporting currency for Prime Medicine?
Prime Medicine reports financial results in USD
What is the latest annual turnover for Prime Medicine?
The latest annual turnover of Prime Medicine is USD 2.98M
What is the latest annual profit for Prime Medicine?
The latest annual profit of Prime Medicine is USD -195.88M
What is the registered address of Prime Medicine?
The registered address for Prime Medicine is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Prime Medicine website address?
The website address for Prime Medicine is www.primemedicine.com
Which industry sector does Prime Medicine operate in?
Prime Medicine operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AADIAadi Bioscience Inc
$ 2.05
(0.00%)
0
AACIUArmada Acquisition Corporation II
$ 10.14
(0.00%)
0
AACGATA Creativity Global
$ 0.82
(0.00%)
22
AACBUArtius II Acquisition Inc
$ 10.50
(0.00%)
0
AACBArtius II Acquisition Inc
$ 10.14
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.05
(0.00%)
0
AACIUArmada Acquisition Corporation II
$ 10.14
(0.00%)
0
AACGATA Creativity Global
$ 0.82
(0.00%)
22
AACBUArtius II Acquisition Inc
$ 10.50
(0.00%)
0
AACBArtius II Acquisition Inc
$ 10.14
(0.00%)
0
DFLIDragonfly Energy Holdings Corporation
$ 0.218
(0.00%)
166.03M
PCSAProcessa Pharmaceuticals Inc
$ 0.242
(0.00%)
60.87M
WLGSWang and Lee Group Inc
$ 0.058
(0.00%)
49.02M
HCTIHealthcare Triangle Inc
$ 0.0265
(0.00%)
40.98M
GNLNGreenlane Holdings Inc
$ 0.01035
(0.00%)
40.56M

PRME Discussion

View Posts
Monksdream Monksdream 2 months ago
PRME under $2
👍️0
Monksdream Monksdream 2 months ago
PRME under $2
👍️0
Monksdream Monksdream 6 months ago
PRME, under $

👍️0
PonkenPlonken PonkenPlonken 7 months ago
Super super undervalued..
Recent PSTX - Roche deal should have made this run? Atleast given it also recently partnered with BMS... makes zero sense.
Is a clear validation CRISPR genome editing is hot in cancer cell therapy.
Waiting for a sign....
👍️0
Monksdream Monksdream 8 months ago
PRME under $5
👍️0
Monksdream Monksdream 9 months ago
PRME new 52 week low
👍️0
Invest-in-America Invest-in-America 9 months ago
PRME: Glad I grabbed a chunk of THIS ONE!!!!
👍️0
PonkenPlonken PonkenPlonken 9 months ago
"Under the terms of the agreement, Prime Medicine will receive a $55 million upfront payment and a $55 million equity investment from Bristol Myers Squibb. Prime Medicine is also eligible to receive more than $3.5 billion in milestones,..."

"On the Effective Date, the Company entered into the Purchase Agreement with BMS, pursuant to which the Company agreed to issue and sell, and BMS agreed to purchase, in an unregistered offering (the “Offering”), 11,006,163 shares [...] for an aggregate purchase price of $55.0 million..."
👍️0
Monksdream Monksdream 9 months ago
PRME new 52=week low
👍️0
wiwineguy wiwineguy 10 months ago
K. I'm in!
👍️0
Monksdream Monksdream 10 months ago
DAKT
👍️0
wiwineguy wiwineguy 10 months ago
You are amazing Monk. Any recommendations
👍️0
Monksdream Monksdream 10 months ago
PRME under $5
👍️0
Monksdream Monksdream 10 months ago
PRME new 52 week low
👍️0
Monksdream Monksdream 11 months ago
PRME under $6
👍️0
Monksdream Monksdream 12 months ago
PRME under $10:
👍️0
Monksdream Monksdream 1 year ago
Great post
Friday Cathie Wood bought more shares for her flagship Ark Fund (ARKK)
I think she has been buying on the decline
She isn’t particularly interested in how well or how lousy the management controls costs it’s the potential she believes exists
There are about a dozen, if not more, listed gene editing companies
Not all will make it before they run out of money and have to raise more operating capital
Notice the $2 to $4 bounces on the way to lower lows
👍️0
Monksdream Monksdream 1 year ago
PRME under $10
👍️0
jondoeuk jondoeuk 1 year ago
PRME vs Tome vs Tessera vs NTLA vs CRSP vs...!

They fact this article needs to be written could mean a legal battle is coming https://www.nature.com/articles/s41587-024-02208-0
👍️0
NY1972 NY1972 1 year ago
This $500M company burns $200M a year. These PhDs have been spoiled by Wall St. when money was cheap. Who wants to be their sugar daddy?
👍️0
jondoeuk jondoeuk 1 year ago
I'm sure in the (near) future they will (functionally) cure (rare) diseases, but not before they dilute a whole bunch more.
👍️0
jondoeuk jondoeuk 1 year ago
The CEO has been contently telling investors how easy it would be to bring in funding through partnerships and how difficult capital markets are. Yet they did a secondary. He needs to go. Also, I don't think their IP is gatekeeping others.
👍️0

Your Recent History

NASDAQ
PRME
Prime Medicine
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads